Search for Indicators
Disparities Dashboard
Indicator Gauge Icon Legend
Legend Colors
Red is bad, green is good, blue is not statistically different/neutral.
Compared to Distribution
the value is in the best half of communities.
the value is in the 2nd worst quarter of communities.
the value is in the worst quarter of communities.
Compared to Target
meets target; 
does not meet target.
Compared to a Single Value
lower than the comparison value;
higher than the comparison value;
not statistically different from comparison value.
Trend
non-significant change over time; 
significant change over time; 
no change over time.
Compared to Prior Value
higher than the previous measurement period;
lower than the previous measurement period;
no statistically different change  from previous measurement period.
Significantly better than the overall value
Significantly worse than the overall value
Significantly different than the overall value
No significant difference with the overall value
No data on significance available
State: Michigan
Health / Alcohol & Drug Use
Value
Compared to:
State: Michigan Age-Adjusted Drug and Opioid-Involved Overdose Death Rate
State: Michigan Age-Adjusted Drug and Opioid-Involved Overdose Death Rate
26.5
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(23.5)
The regional value is compared to the national value.
Prior Value
(27.1)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
State: Michigan
Health / Cancer
Value
Compared to:
State: Michigan Age-Adjusted Death Rate due to Breast Cancer
State: Michigan Age-Adjusted Death Rate due to Breast Cancer
20.2
Deaths per 100,000 females
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(19.6)
The regional value is compared to the national value.
Prior Value
(20.4)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(15.3)
State: Michigan Age-Adjusted Death Rate due to Cancer
State: Michigan Age-Adjusted Death Rate due to Cancer
160.6
Deaths per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(149.4)
The regional value is compared to the national value.
Prior Value
(162.7)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(122.7)
State: Michigan Age-Adjusted Death Rate due to Colorectal Cancer
State: Michigan Age-Adjusted Death Rate due to Colorectal Cancer
13.4
Deaths per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(13.1)
The regional value is compared to the national value.
Prior Value
(13.5)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(8.9)
State: Michigan Age-Adjusted Death Rate due to Lung Cancer
State: Michigan Age-Adjusted Death Rate due to Lung Cancer
40.6
Deaths per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(35.0)
The regional value is compared to the national value.
Prior Value
(42.3)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(25.1)
State: Michigan Age-Adjusted Death Rate due to Prostate Cancer
State: Michigan Age-Adjusted Death Rate due to Prostate Cancer
18.6
Deaths per 100,000 males
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(18.8)
The regional value is compared to the national value.
Prior Value
(18.4)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(16.9)
State: Michigan All Cancer Incidence Rate
State: Michigan All Cancer Incidence Rate
438.2
Cases per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 48 U.S. states and the District of Columbia.
US Value
(442.3)
The regional value is compared to the national value.
Prior Value
(446.7)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Breast Cancer Incidence Rate
State: Michigan Breast Cancer Incidence Rate
122.7
Cases per 100,000 females
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 48 U.S. states and the District of Columbia.
US Value
(127.0)
The regional value is compared to the national value.
Prior Value
(124.2)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Cancer: Medicare Population
State: Michigan Cancer: Medicare Population
11.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(12.0%)
The regional value is compared to the national value.
Prior Value
(11.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Colorectal Cancer Incidence Rate
State: Michigan Colorectal Cancer Incidence Rate
35.6
Cases per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 48 U.S. states and the District of Columbia.
US Value
(36.5)
The regional value is compared to the national value.
Prior Value
(36.9)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Lung and Bronchus Cancer Incidence Rate
State: Michigan Lung and Bronchus Cancer Incidence Rate
59.6
Cases per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 48 U.S. states and the District of Columbia.
US Value
(54.0)
The regional value is compared to the national value.
Prior Value
(61.6)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Mammography Screening: Medicare Population
State: Michigan Mammography Screening: Medicare Population
49.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(47.0%)
The regional value is compared to the national value.
Prior Value
(47.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Oral Cavity and Pharynx Cancer Incidence Rate
State: Michigan Oral Cavity and Pharynx Cancer Incidence Rate
11.8
Cases per 100,000 population
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 48 U.S. states and the District of Columbia.
US Value
(11.9)
The regional value is compared to the national value.
Prior Value
(11.9)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Prostate Cancer Incidence Rate
State: Michigan Prostate Cancer Incidence Rate
112.1
Cases per 100,000 males
(2016-2020)
Compared to:
U.S. States
The distribution is based on data from 48 U.S. states and the District of Columbia.
US Value
(110.5)
The regional value is compared to the national value.
Prior Value
(110.6)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Health / Diabetes
Value
Compared to:
State: Michigan Age-Adjusted Death Rate due to Diabetes
State: Michigan Age-Adjusted Death Rate due to Diabetes
23.4
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(22.6)
The regional value is compared to the national value.
Prior Value
(22.1)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Diabetes: Medicare Population
State: Michigan Diabetes: Medicare Population
25.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(24.0%)
The regional value is compared to the national value.
Prior Value
(25.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Health / Disabilities
Value
Compared to:
State: Michigan Persons with a Cognitive Difficulty
State: Michigan Persons with a Cognitive Difficulty
6.0%
(2018-2022)
Compared to:
US Value
(5.3%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Persons with a Disability
State: Michigan Persons with a Disability
14.1%
(2018-2022)
Compared to:
US Value
(12.9%)
The regional value is compared to the national value.
Prior Value
(14.1%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Persons with a Disability
State: Michigan Persons with a Disability
14.1%
(2018-2022)
Compared to:
US Value
(12.9%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Persons with a Hearing Difficulty
State: Michigan Persons with a Hearing Difficulty
3.8%
(2018-2022)
Compared to:
US Value
(3.6%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Persons with a Self-Care Difficulty
State: Michigan Persons with a Self-Care Difficulty
2.8%
(2018-2022)
Compared to:
US Value
(2.6%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Persons with a Vision Difficulty
State: Michigan Persons with a Vision Difficulty
2.2%
(2018-2022)
Compared to:
US Value
(2.4%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Persons with an Ambulatory Difficulty
State: Michigan Persons with an Ambulatory Difficulty
7.2%
(2018-2022)
Compared to:
US Value
(6.7%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Health / Health Care Access & Quality
Value
Compared to:
State: Michigan Adults with Health Insurance: 18-64
State: Michigan Adults with Health Insurance: 18-64
92.9%
(2021)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
Prior Value
(92.2%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Out-of-Pocket Health Care Spending
State: Michigan Out-of-Pocket Health Care Spending
18.3%
(2021)
Compared to:
US Value
(16.8%)
The regional value is compared to the national value.
Prior Value
(15.5%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Persons with Health Insurance
State: Michigan Persons with Health Insurance
94.0%
(2021)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
Prior Value
(93.6%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(92.4%)
<div>AHS-01: Increase the proportion of people with health insurance <strong>(LEADING HEALTH INDICATOR)</strong></div>
State: Michigan Persons with Private Health Insurance Only
State: Michigan Persons with Private Health Insurance Only
54.5%
(2022)
Compared to:
US Value
(54.8%)
The regional value is compared to the national value.
Prior Value
(54.6%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Persons with Public Health Insurance Only
State: Michigan Persons with Public Health Insurance Only
25.1%
(2022)
Compared to:
US Value
(24.8%)
The regional value is compared to the national value.
Prior Value
(24.5%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Preventable Hospital Stays: Medicare Population
State: Michigan Preventable Hospital Stays: Medicare Population
3,261.0
Discharges per 100,000 Medicare enrollees
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(2,677.0)
The regional value is compared to the national value.
Prior Value
(3,253.0)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Health / Health Information Technology
Value
Compared to:
State: Michigan Persons with an Internet Subscription
State: Michigan Persons with an Internet Subscription
90.8%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(91.0%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Health / Heart Disease & Stroke
Value
Compared to:
State: Michigan Age-Adjusted Death Rate due to Cerebrovascular Disease (Stroke)
State: Michigan Age-Adjusted Death Rate due to Cerebrovascular Disease (Stroke)
41.3
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(37.6)
The regional value is compared to the national value.
Prior Value
(39.5)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(33.4)
State: Michigan Age-Adjusted Death Rate due to Coronary Heart Disease
State: Michigan Age-Adjusted Death Rate due to Coronary Heart Disease
112.2
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(90.2)
The regional value is compared to the national value.
Prior Value
(112.0)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(71.1)
State: Michigan Age-Adjusted Death Rate due to Heart Attack
State: Michigan Age-Adjusted Death Rate due to Heart Attack
48.4
Deaths per 100,000 population 35+ years
(2021)
Compared to:
Prior Value
(48.3)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Atrial Fibrillation: Medicare Population
State: Michigan Atrial Fibrillation: Medicare Population
15.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(14.0%)
The regional value is compared to the national value.
Prior Value
(14.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Heart Failure: Medicare Population
State: Michigan Heart Failure: Medicare Population
13.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(11.0%)
The regional value is compared to the national value.
Prior Value
(13.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Hyperlipidemia: Medicare Population
State: Michigan Hyperlipidemia: Medicare Population
62.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(65.0%)
The regional value is compared to the national value.
Prior Value
(61.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Hypertension: Medicare Population
State: Michigan Hypertension: Medicare Population
66.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(65.0%)
The regional value is compared to the national value.
Prior Value
(66.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Ischemic Heart Disease: Medicare Population
State: Michigan Ischemic Heart Disease: Medicare Population
22.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(21.0%)
The regional value is compared to the national value.
Prior Value
(22.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Stroke: Medicare Population
State: Michigan Stroke: Medicare Population
6.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(6.0%)
The regional value is compared to the national value.
Prior Value
(6.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Health / Immunizations & Infectious Diseases
Value
Compared to:
State: Michigan Age-Adjusted Death Rate due to Influenza and Pneumonia
State: Michigan Age-Adjusted Death Rate due to Influenza and Pneumonia
13.9
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(13.4)
The regional value is compared to the national value.
Prior Value
(13.8)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Flu Vaccinations: Medicare Population
State: Michigan Flu Vaccinations: Medicare Population
47.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(50.0%)
The regional value is compared to the national value.
Prior Value
(47.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Pneumonia Vaccinations: Medicare Population
State: Michigan Pneumonia Vaccinations: Medicare Population
7.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(8.0%)
The regional value is compared to the national value.
Prior Value
(5.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Health / Mental Health & Mental Disorders
Value
Compared to:
State: Michigan Age-Adjusted Death Rate due to Suicide
State: Michigan Age-Adjusted Death Rate due to Suicide
14.4
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(13.9)
The regional value is compared to the national value.
Prior Value
(14.5)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(12.8)
<div>MHMD-01: Reduce the suicide rate <strong>(LEADING HEALTH INDICATOR)</strong></div>
State: Michigan Depression: Medicare Population
State: Michigan Depression: Medicare Population
18.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(16.0%)
The regional value is compared to the national value.
Prior Value
(18.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Health / Older Adults
Value
Compared to:
State: Michigan Adults 65+ with a Hearing Difficulty
State: Michigan Adults 65+ with a Hearing Difficulty
13.6%
(2018-2022)
Compared to:
US Value
(13.7%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Adults 65+ with a Self-Care Difficulty
State: Michigan Adults 65+ with a Self-Care Difficulty
6.8%
(2018-2022)
Compared to:
US Value
(7.4%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Adults 65+ with a Vision Difficulty
State: Michigan Adults 65+ with a Vision Difficulty
5.3%
(2018-2022)
Compared to:
US Value
(6.0%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Adults 65+ with an Independent Living Difficulty
State: Michigan Adults 65+ with an Independent Living Difficulty
13.1%
(2018-2022)
Compared to:
US Value
(13.6%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Age-Adjusted Death Rate due to Alzheimer's Disease
State: Michigan Age-Adjusted Death Rate due to Alzheimer's Disease
35.0
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(31.0)
The regional value is compared to the national value.
Prior Value
(34.2)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Alzheimer's Disease or Dementia: Medicare Population
State: Michigan Alzheimer's Disease or Dementia: Medicare Population
7.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(6.0%)
The regional value is compared to the national value.
Prior Value
(7.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Health / Other Conditions
Value
Compared to:
State: Michigan Age-Adjusted Death Rate due to Kidney Disease
State: Michigan Age-Adjusted Death Rate due to Kidney Disease
14.6
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(12.8)
The regional value is compared to the national value.
Prior Value
(14.7)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Chronic Kidney Disease: Medicare Population
State: Michigan Chronic Kidney Disease: Medicare Population
19.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(18.0%)
The regional value is compared to the national value.
Prior Value
(19.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Osteoporosis: Medicare Population
State: Michigan Osteoporosis: Medicare Population
10.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(11.0%)
The regional value is compared to the national value.
Prior Value
(10.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Rheumatoid Arthritis or Osteoarthritis: Medicare Population
State: Michigan Rheumatoid Arthritis or Osteoarthritis: Medicare Population
36.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(35.0%)
The regional value is compared to the national value.
Prior Value
(35.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Health / Prevention & Safety
Value
Compared to:
State: Michigan Age-Adjusted Death Rate due to Falls
State: Michigan Age-Adjusted Death Rate due to Falls
10.3
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(9.8)
The regional value is compared to the national value.
Prior Value
(9.5)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Age-Adjusted Death Rate due to Firearms
State: Michigan Age-Adjusted Death Rate due to Firearms
13.0
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(12.0)
The regional value is compared to the national value.
Prior Value
(11.9)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(10.7)
State: Michigan Age-Adjusted Death Rate due to Unintentional Injuries
State: Michigan Age-Adjusted Death Rate due to Unintentional Injuries
52.9
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(51.6)
The regional value is compared to the national value.
Prior Value
(51.7)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(43.2)
State: Michigan Age-Adjusted Death Rate due to Unintentional Poisonings
State: Michigan Age-Adjusted Death Rate due to Unintentional Poisonings
26.6
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(23.5)
The regional value is compared to the national value.
Prior Value
(26.3)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Health / Respiratory Diseases
Value
Compared to:
43.1
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(38.1)
The regional value is compared to the national value.
Prior Value
(44.0)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Asthma: Medicare Population
State: Michigan Asthma: Medicare Population
7.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(7.0%)
The regional value is compared to the national value.
Prior Value
(7.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan COPD: Medicare Population
State: Michigan COPD: Medicare Population
13.0%
(2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(11.0%)
The regional value is compared to the national value.
Prior Value
(14.0%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Health / Sexually Transmitted Infections
Value
Compared to:
State: Michigan Chlamydia Incidence Rate
State: Michigan Chlamydia Incidence Rate
449
Cases per 100,000 population
(2020)
Compared to:
US Value
(481.3)
The regional value is compared to the national value. The source for the national value is National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Prior Value
(504)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Gonorrhea Incidence Rate
State: Michigan Gonorrhea Incidence Rate
234
Cases per 100,000 population
(2020)
Compared to:
US Value
(206.5)
The regional value is compared to the national value. The source for the national value is National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Prior Value
(183)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Community / Crime & Crime Prevention
Value
Compared to:
State: Michigan Age-Adjusted Death Rate due to Homicide
State: Michigan Age-Adjusted Death Rate due to Homicide
7.2
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(6.6)
The regional value is compared to the national value.
Prior Value
(6.4)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(5.5)
<div>IVP-09: Reduce homicides <strong>(LEADING HEALTH INDICATOR)</strong></div>
State: Michigan
Community / Demographics
Value
Compared to:
State: Michigan Foreign Born Persons
State: Michigan Foreign Born Persons
6.9%
(2018-2022)
Compared to:
US Value
(13.7%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Veteran Population
State: Michigan Veteran Population
6.3%
(2018-2022)
Compared to:
US Value
(6.6%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Community / Public Safety
Value
Compared to:
State: Michigan Age-Adjusted Death Rate due to Motor Vehicle Traffic Collisions
State: Michigan Age-Adjusted Death Rate due to Motor Vehicle Traffic Collisions
10.2
Deaths per 100,000 population
(2018-2020)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(11.4)
The regional value is compared to the national value.
Prior Value
(9.6)
Prior Value compares a measured value with the previously measured value. Confidence intervals were taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(10.1)
State: Michigan
Community / Transportation
Value
Compared to:
State: Michigan Households without a Vehicle
State: Michigan Households without a Vehicle
7.2%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(8.3%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Mean Travel Time to Work
State: Michigan Mean Travel Time to Work
24.5
Minutes
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(26.7)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Workers Commuting by Public Transportation
State: Michigan Workers Commuting by Public Transportation
1.1%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(3.8%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(5.3%)
State: Michigan Workers who Drive Alone to Work
State: Michigan Workers who Drive Alone to Work
77.1%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(71.7%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Economy / Housing & Homes
Value
Compared to:
State: Michigan Overcrowded Households
State: Michigan Overcrowded Households
1.6%
(2018-2022)
Compared to:
US Value
(3.3% in 2016-2020)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Renters Spending 30% or More of Household Income on Rent
State: Michigan Renters Spending 30% or More of Household Income on Rent
49.0%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(49.9%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(25.5%)
State: Michigan
Economy / Income
Value
Compared to:
State: Michigan Gender Pay Gap
State: Michigan Gender Pay Gap
$0.68
Cents on the dollar
(2022)
Compared to:
US Value
($0.73)
The regional value is compared to the national value.
Prior Value
($0.70)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Median Household Income
State: Michigan Median Household Income
$68,505
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
($75,149)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Per Capita Income
State: Michigan Per Capita Income
$37,929
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
($41,261)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Economy / Poverty
Value
Compared to:
State: Michigan Children Living Below Poverty Level
State: Michigan Children Living Below Poverty Level
17.8%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(16.7%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Families Living Below Poverty Level
State: Michigan Families Living Below Poverty Level
8.8%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(8.8%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan People 65+ Living Below Poverty Level
State: Michigan People 65+ Living Below Poverty Level
9.0%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(10.0%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan People 65+ Living Below Poverty Level (Count)
State: Michigan People 65+ Living Below Poverty Level (Count)
156,622
People
(2018-2022)
Compared to:
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan People Living Below Poverty Level
State: Michigan People Living Below Poverty Level
13.1%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(12.5%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
HP 2030 Target
(8.0%)
State: Michigan Young Children Living Below Poverty Level
State: Michigan Young Children Living Below Poverty Level
20.1%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(18.1%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan Youth not in School or Working
State: Michigan Youth not in School or Working
2.0%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(1.8%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Education / Educational Attainment
Value
Compared to:
State: Michigan People 25+ with a Bachelor's Degree or Higher
State: Michigan People 25+ with a Bachelor's Degree or Higher
31.1%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(34.3%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan People 25+ with a High School Diploma or Higher
State: Michigan People 25+ with a High School Diploma or Higher
91.8%
(2018-2022)
Compared to:
U.S. States
The distribution is based on data from 50 U.S. states and the District of Columbia.
US Value
(89.1%)
The regional value is compared to the national value.
Trend
This comparison measures the indicator’s values over multiple time periods.<br>The Mann-Kendall Test for Statistical Significance is used to evaluate the trend<br>over 4 to 10 periods of measure, subject to data availability and comparability.
State: Michigan
Environmental Health / Built Environment
Value
Compared to:
State: Michigan Access to Parks
State: Michigan Access to Parks
59.6%
(2020)
Compared to:
Prior Value
(35.9%)
Prior Value compares a measured value with the previously measured value. Confidence intervals were not taken into account in determining the direction of the comparison.
